StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)

Close on Nov 17, 2026Market cap $1.32MP/E –Yield –

PMGC EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

PMGC's EPS for the twelve months ending Sep 30, 2024 was -$442.64, down 100.3% year over year. For fiscal 2023 it was -$560.00.

Annual eps

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$560.00–
FY2022Dec 31, 2022-$264.60–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.01–
Q2 FY2026Jun 30, 2026-$0.60–
Q1 FY2026Mar 31, 2026-$11.17–
Q3 FY2025Sep 30, 2025-$1178.17–
Q2 FY2025Jun 30, 2025-$37.98–
Q1 FY2025Mar 31, 2025-$248.03–
Q3 FY2024Sep 30, 2024-$95.20–
Q2 FY2024Jun 30, 2024-$112.00–
Q1 FY2024Mar 31, 2024-$113.40–
Q4 FY2023Dec 31, 2023-$122.04-100.1%
Q3 FY2023Sep 30, 2023-$109.20–
Q2 FY2023Jun 30, 2023-$179.20–
Q1 FY2023Mar 31, 2023-$155.40–
Q4 FY2022Dec 31, 2022$168278.86–
Q3 FY2022Sep 30, 2022-$72.80–

More PMGC figures

See a number that looks wrong?